Selective cognitive dysfunction and physical disability improvement after autologous hematopoietic stem cell transplantation in highly active multiple sclerosis von Giedraitiene, N., Kizlaitiene, R., Peceliunas, V., Griskevicius, L., Kaubrys, G.

Volltext

Cloud based multicentre multiple sclerosis registry in Lithuania: on line approach for continuous patient care and national data collection von Kizlaitiene, R, Kaubrys, G.F, Jatuzis, D, Kizlaitis, R.J, Liutkiene, J, Giedraitiene, N, Mickeviciene, D, Rastenyte, D, Vaitkus, A, Malciene, L

Volltext

Evaluation of the retinal nerve fiber layer thickness and its relation to visual evoked potentials in multiple sclerosis von Strupaite, R., Mockeviciute, E., Kizlaitiene, R., Budrys, V., Liveikiene, A., Mamontovaite, G., Cimbalas, A., Asoklis, R.

Volltext

Relationship between the working capacity level and the results of the brief ICF core set for multiple sclerosis von Valadkeviciene, D., Kizlaitiene, R., Jatuzis, D.

Volltext

Cognitive changes assessed during MS relapse with bicams and computerized cantab tests von Giedraitiene, N., Kizlaitiene, R., Kaubrys, G.

Volltext

Co-occurrence of Myasthenia Gravis and Multiple Sclerosis: A Case Report von Rynkevič, G., Kizlaitienė, R.

Volltext

Religiosity and superstitions in chronic neurological disorders von Mameniskiene, R., Serbentaite, I., Kaladyte Lokominiene, R., Kizlaitiene, R.

Volltext

The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab von Jonušaitė, I., Giedraitienė, N., Kaubrys, G., Kizlaitienė, R.

Volltext

FP39-WE-03 Long-term immunomodulating treatment in relapsing-remitting multiple sclerosis: how to reduce the number of drop-out patients von Kizlaitiene, R, Budrys, V, Kaubrys, G, Liutkiene, J, Petrauskiene, D, Kizlaitis, R.J

Volltext

Incidence rate and sex ratio in multiple sclerosis in Lithuania von Valadkeviciene, Daiva, Kavaliunas, Andrius, Kizlaitiene, Rasa, Jocys, Mykolas, Jatuzis, Dalius

Volltext

Treatment of Multiple Sclerosis with Cladribine Tablets: Literature Review and the Guidance of the Lithuanian Association of Neurologists von Kizlaitienė, R., Mickevičienė, D., Malcienė, L., Giedraitienė, N., Balnytė, R., Jatužis, D.

Volltext

TOP20 Body Functions, Activities and Participation Categories Affecting Work Capacity Level of Multiple Sclerosis Patients: WHO Comprehensive ICF Core Set for Multiple Sclerosis Re... von Valadkeviciene, D, Zukauskaite, I, Karrenbauer, VD, Bileviciute-Ljungar, I, Kizlaitiene, R, Jatuzis, D

Volltext

Multiple sclerosis: overview of orally administrated disease-modifying drugs. Do genetics influence the success of treatment? von Ovčinikova, A., Kizlaitienė, R.

Volltext

Relationship between circadian rhythm characteristics and chronotypes with multiple sclerosis: literature review von Jonušaitė, Ieva, Sakalauskaitė-Juodeikienė, Eglė, Mameniškienė, Rūta, Kizlaitienė, R.

Volltext

The role of neurofilament light chain in the context of neurological disorders von Taluntienė, V., Motiekaitytė, R., Kizlaitienė, R., Giedraitienė, N., Kaubrys, G.

Volltext

Recommendations for the treatment of multiple sclerosis with disease-modifying drugs during the COVID-19 pandemic von Kizlaitienė, R., Giedraitienė, N., Sereikė, I., Liutkienė, J., Leščinskienė, L., Kaubrys, G.

Volltext

Phase III dose-comparison study of glatiramer acetate for multiple sclerosis von Comi, Giancarlo, Cohen, Jeffrey A., Arnold, Douglas L., Wynn, Daniel, Filippi, Massimo

Volltext

Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results von Giovannoni, G, Barbarash, O, Casset-Semanaz, F, King, J, Metz, L, Pardo, G, Simsarian, J, Sørensen, PS, Stubinski, B

Volltext

Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing—remitting multiple sclerosis von De Stefano, Nicola, Curtin, François, Stubinski, Bettina, Blevins, Gregg, Drulovic, Jelena, Issard, Delphine, Shotekov, Penko, Gasperini, Claudio, IMPROVE study investigators

Volltext

Prevalence of multiple sclerosis in Lithuania and the influence of immunomodulating treatment on annual hospitalization von Kizlaitiene, R, Budrys, V, Kaubrys, G, Runkauskaite, I, Petrauskiene, D

Volltext